63 results
424B3
KA
Kineta Inc
13 Nov 23
Prospectus supplement
5:28pm
to recruit and enroll suitable patients in our clinical trials;
the potential attributes and benefits of our product candidates;
our ability to develop
424B5
KA
Kineta Inc
5 Oct 23
Prospectus supplement for primary offering
10:47am
and development programs;
our ability to recruit and enroll suitable patients in our clinical trials;
the potential attributes and benefits of our product … , the period during which the results of the trials will become available and our research and development programs;
our ability to recruit and enroll
8-K
EX-99.1
vrz zdagcx
11 Aug 23
Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
424B3
ol74o44fr tc5z5u
12 Jun 23
Prospectus supplement
5:01pm
424B5
59tam9f5msc
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.5
o0iz5 8a1m4rm1
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
kykgaqiw tdrhi6
10 Nov 22
Prospectus supplement
4:21pm